Johan Riesenfeld

2.1k total citations
37 papers, 1.8k citations indexed

About

Johan Riesenfeld is a scholar working on Cell Biology, Hematology and Surgery. According to data from OpenAlex, Johan Riesenfeld has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cell Biology, 13 papers in Hematology and 11 papers in Surgery. Recurrent topics in Johan Riesenfeld's work include Proteoglycans and glycosaminoglycans research (20 papers), Platelet Disorders and Treatments (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Johan Riesenfeld is often cited by papers focused on Proteoglycans and glycosaminoglycans research (20 papers), Platelet Disorders and Treatments (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Johan Riesenfeld collaborates with scholars based in Sweden, United States and Norway. Johan Riesenfeld's co-authors include Ulf Lindahl, Magnus Höök, L Thunberg, Per Olsson, Tom Eirik Mollnes, G. Bäckström, Graciela Elgue, Ingemar Björk, Kerstin Nordling and Javier Sánchez and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Johan Riesenfeld

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Riesenfeld Sweden 28 826 692 400 375 255 37 1.8k
Paul S. Damus United States 14 491 0.6× 527 0.8× 971 2.4× 401 1.1× 104 0.4× 16 2.1k
Douglas J. Goetz United States 28 251 0.3× 852 1.2× 182 0.5× 139 0.4× 59 0.2× 59 2.2k
Jean‐Pierre Vannier France 28 187 0.2× 738 1.1× 381 1.0× 395 1.1× 30 0.1× 81 2.5k
Rivka Ishai-Michaeli Israel 20 2.0k 2.5× 2.0k 2.9× 433 1.1× 195 0.5× 355 1.4× 23 2.9k
Gene A. Homandberg United States 33 621 0.8× 933 1.3× 112 0.3× 364 1.0× 85 0.3× 80 3.1k
Dominique Bihan United Kingdom 29 265 0.3× 825 1.2× 319 0.8× 152 0.4× 92 0.4× 56 2.4k
Madhu M. Bhargava United States 30 250 0.3× 1.2k 1.8× 42 0.1× 889 2.4× 84 0.3× 72 2.7k
Peter Ruminski United States 16 166 0.2× 595 0.9× 117 0.3× 208 0.6× 104 0.4× 42 2.0k
Hirohiko Ise Japan 27 184 0.2× 952 1.4× 42 0.1× 661 1.8× 69 0.3× 72 2.0k
A K McNally United States 9 83 0.1× 312 0.5× 54 0.1× 273 0.7× 81 0.3× 9 1.3k

Countries citing papers authored by Johan Riesenfeld

Since Specialization
Citations

This map shows the geographic impact of Johan Riesenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Riesenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Riesenfeld more than expected).

Fields of papers citing papers by Johan Riesenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Riesenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Riesenfeld. The network helps show where Johan Riesenfeld may publish in the future.

Co-authorship network of co-authors of Johan Riesenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Riesenfeld. A scholar is included among the top collaborators of Johan Riesenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Riesenfeld. Johan Riesenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, Jonas, et al.. (2014). Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption. Journal of Biomedical Materials Research Part B Applied Biomaterials. 102(8). 1817–1824. 49 indexed citations
2.
Falotico, Robert, et al.. (2012). A nonelutable low‐molecular weight heparin stent coating for improved thromboresistance. Journal of Biomedical Materials Research Part B Applied Biomaterials. 100B(5). 1274–1282. 11 indexed citations
3.
Brekke, Ole‐Lars, Dorte Christiansen, Hilde Fure, et al.. (2008). Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood. Molecular Immunology. 45(14). 3804–3813. 53 indexed citations
4.
Lappegård, Knut Tore, Grethe Bergseth, Johan Riesenfeld, et al.. (2007). The artificial surface‐induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent. Journal of Biomedical Materials Research Part A. 87A(1). 129–135. 38 indexed citations
5.
Lappegård, Knut Tore, Johan Riesenfeld, Ole‐Lars Brekke, et al.. (2005). Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production. The Annals of Thoracic Surgery. 79(3). 917–923. 25 indexed citations
6.
Lappegård, Knut Tore, Grethe Bergseth, Johan Riesenfeld, Joe Sexton, & Tom Eirik Mollnes. (2005). Role of granulocytes and monocytes in the polyvinyl chloride‐induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4. Journal of Biomedical Materials Research Part A. 74A(2). 230–236. 6 indexed citations
7.
Lappegård, Knut Tore, Michael Fung, Grethe Bergseth, et al.. (2004). Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation. The Annals of Thoracic Surgery. 77(3). 932–941. 58 indexed citations
8.
Lappegård, Knut Tore, Michael Fung, Grethe Bergseth, Johan Riesenfeld, & Tom Eirik Mollnes. (2004). Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. The Annals of Thoracic Surgery. 78(1). 38–44. 35 indexed citations
9.
Sánchez, Javier, Graciela Elgue, Johan Riesenfeld, & Per Olsson. (1998). Studies of Adsorption, Activation, and Inhibition of Factor XII on Immobilized Heparin. Thrombosis Research. 89(1). 41–50. 72 indexed citations
10.
Elgue, Graciela, et al.. (1997). Inhibition of the plasma contact activation system of immobilized heparin: Relation to surface density of functional antithrombin binding sites. Journal of Biomedical Materials Research. 37(1). 37–42. 35 indexed citations
11.
12.
Sánchez, J., Graciela Elgue, Johan Riesenfeld, & Per Olsson. (1995). Control of contact activation on end‐point immobilized heparin: The role of antithrombin and the specific antithrombin‐binding sequence. Journal of Biomedical Materials Research. 29(5). 655–661. 39 indexed citations
13.
Elgue, Graciela, Javier Sánchez, Nils Egberg, Per Olsson, & Johan Riesenfeld. (1993). Effect of Surface‐Immobilized Heparin on the Activation of Adsorbed Factor XII. Artificial Organs. 17(8). 721–726. 22 indexed citations
14.
Riesenfeld, Johan & Lennart Rodén. (1990). Quantitative analysis of N-sulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Analytical Biochemistry. 188(2). 383–389. 21 indexed citations
15.
Lidholt, Kerstin, Johan Riesenfeld, Karin Jacobsson, David S. Feingold, & Ulf Lindahl. (1988). Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system. Biochemical Journal. 254(2). 571–578. 33 indexed citations
16.
Riesenfeld, Johan, Inger Pettersson, Ulf Lindahl, Willie F. Vann, & Lennart Rodén. (1987). Biosynthesis of heparin. Glycoconjugate Journal. 4(2). 179–189. 5 indexed citations
17.
Riesenfeld, Johan, et al.. (1982). Biosynthesis of heparan sulfate in rat liver. Characterization of polysaccharides obtained with intact cells and with a cell-free system.. Journal of Biological Chemistry. 257(12). 7050–7055. 49 indexed citations
18.
Riesenfeld, Johan, Magnus Höök, & Ulf Lindahl. (1982). Biosynthesis of heparin. Concerted action of early polymer-modification reactions.. Journal of Biological Chemistry. 257(1). 421–425. 33 indexed citations
19.
Höök, Magnus, Johan Riesenfeld, & Ulf Lindahl. (1982). N-[3H]acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Analytical Biochemistry. 119(2). 236–245. 108 indexed citations
20.
Lindahl, Ulf, Magnus Höök, G. Bäckström, et al.. (1977). Structure and biosynthesis of heparin-like polysaccharides.. PubMed. 36(1). 19–24. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul S. Damus Breakdown of academic impact, for papers by Douglas J. Goetz Breakdown of academic impact, for papers by Jean‐Pierre Vannier Breakdown of academic impact, for papers by Rivka Ishai-Michaeli Breakdown of academic impact, for papers by Gene A. Homandberg Breakdown of academic impact, for papers by Dominique Bihan Breakdown of academic impact, for papers by Madhu M. Bhargava Breakdown of academic impact, for papers by Peter Ruminski Breakdown of academic impact, for papers by Hirohiko Ise Breakdown of academic impact, for papers by A K McNally
Rankless by CCL
2026